about
p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple stepsThe ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositisSWI/SNF-directed stem cell lineage specification: dynamic composition regulates specific stages of skeletal myogenesisActivation of MyoD-dependent transcription by cdk9/cyclin T2Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirinDifferential roles of p300 and PCAF acetyltransferases in muscle differentiationBinding of CDK9 to TRAF2A systems approach reveals that the myogenesis genome network is regulated by the transcriptional repressor RP58MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regionsFunctional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration.Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells.p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcriptionStage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases.Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis.TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration.The link between chromatin structure, protein acetylation and cellular differentiation.Phosphoryl-EZH-ion.Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells.Decreased expression of monocarboxylate transporter 1 and 4 in the branching airway epithelium of nitrofen-induced congenital diaphragmatic hernia.Signaling to the chromatin during skeletal myogenesis: novel targets for pharmacological modulation of gene expression.The epigenetic network regulating muscle development and regeneration.Epigenetic control of reprogramming and cellular differentiation.Myosin phosphatase modulates the cardiac cell fate by regulating the subcellular localization of Nkx2.5 in a Wnt/Rho-associated protein kinase-dependent pathway.TBP/TFIID-dependent activation of MyoD target genes in skeletal muscle cells.Deficiency of platelet-derived growth factor receptor-α-positive cells in Hirschsprung's disease colon.Altered tryptophan hydroxylase 2 expression in enteric serotonergic nerves in Hirschsprung's-associated enterocolitis.Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obese.Protein Kinase A: A Master Kinase of Granulosa Cell DifferentiationThe Worsening Profile of Alcoholic Hepatitis in the United States.HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.Epigenetic drugs in the treatment of skeletal muscle atrophy.Regenerative pharmacology in the treatment of genetic diseases: the paradigm of muscular dystrophy"Mix of Mics"- Phenotypic and Biological Heterogeneity of "Multipotent" Muscle Interstitial Cells (MICs).SWI/SNF complexes, chromatin remodeling and skeletal myogenesis: it's time to exchange!Epigenetic regulation of skeletal myogenesis.Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases.SIRT1 signaling as potential modulator of skeletal muscle diseases.Reactive oxygen intermediates (ROIs) are involved in the intracellular transduction of angiotensin II signal in C2C12 cells.RETRACTED: Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma.
P50
Q24554203-F51AA381-2A88-4AC5-937C-E993900788B6Q27301955-4A1B32CA-516E-4D1F-9D2E-30EA60993C79Q28078894-A8782BF3-0FE6-4F0C-9CD0-5108D1FCEA47Q28115623-A4927FA7-22FE-4213-82A1-C9F2135E5CAAQ28195708-A56ED677-F523-466A-BA5B-73A6388B8604Q28276083-D5D5A1BA-3E5D-4EAC-94D2-420CD1B22BFFQ28289684-85FF457D-2854-47FF-91C3-FEAF7DDB4D0BQ28587674-6C44C0E6-2457-46EF-AC14-40285CEC93F0Q28589051-8223529E-4F17-4277-8D9F-2DEB99ED785BQ30439474-92D0DE0D-9AE9-4C29-8DBA-A4D2F58A6C27Q33593168-C9CE066C-4A85-4FE8-8399-DDC839239C87Q33707676-D93FFCD8-7FD2-407F-9691-7B6C33ACC673Q33886012-6771525A-C5E8-49D5-849F-FE32DA2AD432Q34065460-214E35BA-4FC6-455F-BDF4-59AA28D31B47Q34099613-81772F5C-7B1B-4D1A-BC53-2DA96CC9EAE3Q34181742-2FC0B786-E951-4587-9996-9AA1AE19E7FBQ34353494-EB71BA28-D37D-4A4B-9D7F-23CB21030724Q35194032-8F1133F2-CC34-47E4-9C6A-544F84E4C0AEQ35232680-19E858D6-269F-4B9E-80CB-4191E303664AQ35964150-CA07A22A-B454-416C-8095-37FBA7294BBBQ36243868-0FE2D991-68D7-4D45-9839-5FE45A62F460Q36254977-34687711-F251-436F-BD4A-684361190F7AQ36277560-4B135D33-E008-4FE2-A348-9E5305C72D55Q36545299-D37DA2E0-EEE5-434C-A8B5-3E4A0B47F7E8Q36642182-B8225083-B282-4E66-9C21-0CE1D3E06733Q36724352-AE40F5CC-8BEC-4477-BE85-D3AC9343D312Q36909234-4B083285-F86D-4B88-9D03-0E8781A8B702Q36930189-9D24BC7F-EAE0-4CCF-AF1C-ECAE85881B6DQ37024139-6E4670E2-3A15-4A41-896A-6CC363986B42Q37033009-6A153D5A-933F-43BD-A09D-560A974C70E1Q37039472-BB904F99-9DAF-4E54-85CB-D228152989CCQ37088443-70E6B5F2-1602-4B71-BE46-793E47F1C6B9Q37274303-899ECC5F-4802-4A0C-A1FD-284F6D994EEFQ37637940-D079F111-7E80-4E05-9FFF-5D7D7457F2E2Q37765666-B6547141-B805-4E8C-9646-533F3603F0CCQ37769116-B409489B-CBDA-4271-A3A9-7451543E5318Q37838730-E7725BBD-E589-434E-B4F9-F9A7B8CE4832Q37991826-A35DE4B3-6114-4AC2-911F-C0A30A19D725Q38297415-3651D8B2-7256-4740-8A50-7B9EB236C280Q38355978-911370D1-306A-4AE1-9C6E-502BAE370647
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pier Lorenzo Puri
@an
Pier Lorenzo Puri
@ast
Pier Lorenzo Puri
@br
Pier Lorenzo Puri
@ca
Pier Lorenzo Puri
@co
Pier Lorenzo Puri
@da
Pier Lorenzo Puri
@de
Pier Lorenzo Puri
@en
Pier Lorenzo Puri
@es
Pier Lorenzo Puri
@eu
type
label
Pier Lorenzo Puri
@an
Pier Lorenzo Puri
@ast
Pier Lorenzo Puri
@br
Pier Lorenzo Puri
@ca
Pier Lorenzo Puri
@co
Pier Lorenzo Puri
@da
Pier Lorenzo Puri
@de
Pier Lorenzo Puri
@en
Pier Lorenzo Puri
@es
Pier Lorenzo Puri
@eu
prefLabel
Pier Lorenzo Puri
@an
Pier Lorenzo Puri
@ast
Pier Lorenzo Puri
@br
Pier Lorenzo Puri
@ca
Pier Lorenzo Puri
@co
Pier Lorenzo Puri
@da
Pier Lorenzo Puri
@de
Pier Lorenzo Puri
@en
Pier Lorenzo Puri
@es
Pier Lorenzo Puri
@eu
P106
P21
P31
P496
0000-0003-4964-0095